de Boer Daniel Anton's Form 4 filing
ProQR Therapeutics N.V. (PRQR) · filed Jul 8, 2026
- Accession no.
- 0001104659-26-081762
- Filed
- Jul 8, 2026, 2:55 PM ET
- Trade date
- Jul 7, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $238.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| de Boer Daniel AntonCIK 0002117546 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Ordinary Shares | PPurchaseAcquired | +150,000 | $1.59 | +$238,500 | 150,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.